Dr. Huilan Rao is the associate professor of Department of Pathology of Sun Yat-sen University Cancer Center. Dr. Rao obtained her Bachelor in Medicine (equivalent to MD in the US) at Huazhong University of Medical Sciences and Master at Sun Yat-sen University of Medical Sciences, P. R. China in 1990 and 1996, respectively. Her extended practical experience with rountie pathological diagnostic techniques includes pathological slides,histochemical and immunohistochemical techniques. She has been working in pathological diagnosis field for 18 years, major in lymphoma and soft tissue tumor diagnosis. She has served as member of clinical multiple department discussion for difficult lymphoma cases at Cancer Center of Sun Yat-sen University. She is appointed as member of Guangdong Province Committee of Anti-cancer Association with Lymphoma. Also she is a member of Guangdong Pathological Cooperative Group of Lymphoma. 

Her postdoctoral training at University of Arizona and observer experience at MD. Anderson Cancer Center in USA provided her with great opportunities to explore the fields of tumorigenesis, EBV-associated lymphoma tumorigenesis, peripheral T/NK lymphoma classification. Dr.Rao has published more than 50 research papers. She obtained her supervisor of postgraduate at Cancer Center of Sun Yat-sen University in 2013.

Lymphoma, soft tissue tumors.

Bachelor of Medicine: Clinic Medicine, Huazhong University of Medical Sciences (Tongji Medical University), Wuhan, Hubei, China, 1985-1990

Master of Medicine: Pathology, Sun Yat-sen University of Medical Sciences, Guangzhou, Guangdong, China, 1993-1996.

Exchange graduate student: Division of Oral Pathology , Niigata Universtiy, Japan, 1995.

Research Associate: Department of Biochemistry & Molecular Biophysics, University of Arizona, USA, 2003-2005.

Fellowship: Department of Pathology, Jiangshu Provincial Hospital , 2011.

Observer: Department of hematopathology, MD.Anderson Cancer Center, USA, 2012.

1.Yangfen F,Huilan R(corresponding author). 2014. Latest WHO classification analysis of mature T-cell and NK-cell lymphoma and CD30 expression. Chin.J.Pathology, Aug.

2.HuiLan R,Chen JW,Li M.2012. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis.PloS One, 2012;7(1):e30806.

3. Cai My,Hou JH,Huilan R(corresponding autor),et al.2011.High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular and predicts worse prognosis in patients. Mol Med .17(1-2):12-20. 

4.Muyan C,Huilan R(corresponding autor),et al. 2010.Angiomyolipoma histopathological subtypes and clinical features. Chin.J.Exp.Surg.9:1249-1250

5.Yangfen F,Huilan R(corresponding author),Qiuliang W,et al. 2009.Clinicopathological and Immunohistochemical Analysis of Solid-pseudopapillary Neoplasm of Pancreas. Journal of Sun YAT-SEN University (Medical Sciences).30(2):200-204.

6. Huilan R,Jinghui Hou, Yili Huang,et al.2001. Clinical pathological characteristics of malignant lymphoepithelial lesion of the salivary glands and its relationship with EV virus. Chin.J.Cancer. 20(3):270-273.

7.Huilan R,Yili Huang,Jinghui Hou,et al.1999. The significance of detection of EB virus and its products in anaplastic large cell lymphoma. Chin.J.Cancer. 18(4):407-409. 

8. Liao H, Huilan R,et al. 2010.Retrospective study of clinicopathological characteristics in bronchopulmonary carcionoid. Chin.J.Lung Cancer.13(6):591-597.

9. Yuhong L,Huilan R,Zhongzhen Guang,et al. 2000.Anaplastic large-cell lymphoma-review and 20 cases report. Chin.J.Cancer.19(9):914-917.

10.Huangxing L,Huilan R,et al.1998. BLEL of salivary gland-a clinical and pathological analysis of 15 cases.Chin.J.Cancer.17(2):126-128.

11..Hanliang L,Huilaln R,Jinhui H,et al. 1998.Clinical pathological characteristics of anaplastic large cell lymphoma and the expression of LMP1.Natl.Med.J.China.78(2):150-151..

12.Hanliang ,Huilan R,Saku,et al. 1997.The significance of detecting EB virus and its products in benign and malignant lymphoepithelial lesions and the salivary glands.Chin.J.Pathol,26(4):225-228.

13.Huangxing L,Huilan R,et al. 1997.The significance of actinotheraphy in the treatment of Midulicz disease. Chin.J.Modern Med. 7(8):12-14.

Updated by International Office, Sun Yat-sen University Cancer Center